| Dr Pedro Miguel Soler Jr, MD | |
|
4144 N. Armenia Ave, Suite 250, Tampa, FL 33607 | |
| (813) 878-9889 | |
| (813) 872-9560 |
| Full Name | Dr Pedro Miguel Soler Jr |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 32 Years |
| Location | 4144 N. Armenia Ave, Tampa, Florida |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134128010 | NPI | - | NPPES |
| 1134128010 | Other | FL | NPI |
| 257171400 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | ME70059 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Florida Hospital Carrollwood | Tampa, FL | Hospital |
| Entity Name | Pedro M Soler Md Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831136001 PECOS PAC ID: 9436256211 Enrollment ID: O20070514000435 |
News Archive
Cyberonics, Inc. today announced results for the quarter ended October 29, 2010.
BlueGnome has pioneered the use of statistical signal modelling in the analysis of high throughput experimental data. Its first product BlueFuse for Microarrays uses statistical modelling techniques to eliminate Œnoise‚ generated in microarray experiments, enabling researchers to automatically identify the presence or absence of genes and proteins with a higher level of confidence than is currently possible.
Generex Biotechnology Corporation today announced presentation of additional results from a recently completed Phase I clinical trial of its novel immunotherapeutic peptide AE37 in prostate cancer patients. AE37 is a synthetic cancer vaccine being developed by Antigen Express, Inc., a wholly owned subsidiary of Generex, for multiple cancer indications.
Icagen, Inc. today announced that, following a review of data from recently completed clinical studies as well as the Company's proposed protocol for a Phase II clinical trial in patients with treatment resistant epilepsy, the FDA has notified the Company that the clinical hold on Icagen's IND for ICA-105665, a novel orally available small molecule KCNQ potassium channel agonist, has been removed.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Pedro Miguel Soler Jr, MD 13015 W Linebaugh Ave Ste 102, Tampa, FL 33626-4506 Ph: (813) 878-9889 | Dr Pedro Miguel Soler Jr, MD 4144 N. Armenia Ave, Suite 250, Tampa, FL 33607 Ph: (813) 878-9889 |
News Archive
Cyberonics, Inc. today announced results for the quarter ended October 29, 2010.
BlueGnome has pioneered the use of statistical signal modelling in the analysis of high throughput experimental data. Its first product BlueFuse for Microarrays uses statistical modelling techniques to eliminate Œnoise‚ generated in microarray experiments, enabling researchers to automatically identify the presence or absence of genes and proteins with a higher level of confidence than is currently possible.
Generex Biotechnology Corporation today announced presentation of additional results from a recently completed Phase I clinical trial of its novel immunotherapeutic peptide AE37 in prostate cancer patients. AE37 is a synthetic cancer vaccine being developed by Antigen Express, Inc., a wholly owned subsidiary of Generex, for multiple cancer indications.
Icagen, Inc. today announced that, following a review of data from recently completed clinical studies as well as the Company's proposed protocol for a Phase II clinical trial in patients with treatment resistant epilepsy, the FDA has notified the Company that the clinical hold on Icagen's IND for ICA-105665, a novel orally available small molecule KCNQ potassium channel agonist, has been removed.
› Verified 3 days ago
Daniel Diaco, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 4700 North Habana Avenue, Suite 400, Tampa, FL 33614 Phone: 813-876-3611 Fax: 813-387-1745 | |
Dr. Naji Kamal Baddoura, M. D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 14434 Bruce B Downs Blvd, Tampa, FL 33613 Phone: 813-971-1010 Fax: 813-632-8670 | |
Dr. Moriah R Moffitt, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 508 S Habana Ave, Suite 180, Tampa, FL 33609 Phone: 813-414-0908 Fax: 813-414-9354 | |
Shay Cannon, PA Plastic Surgery Medicare: Medicare Enrolled Practice Location: 2 Tampa General Cir, Tampa, FL 33606 Phone: 813-821-8724 | |
Dr. Lewis Herman Berger, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2901 W Saint Isabel St, Suite 2c, Tampa, FL 33607 Phone: 813-877-7658 Fax: 813-872-8305 | |
Meegan Minori Gruber, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 6319 Memorial Hwy, Tampa, FL 33615 Phone: 813-886-9090 |